Drug Trials Snapshot: COBENFY
Summary
COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, and is used for the treatment of schizophrenia in ...
Description
COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, and is used for the treatment of schizophrenia in ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source